Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy. (Q40346737)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Mi Kyong Joung

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

5

Doo Ryeon Chung

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

8

Eun-Jeong Joo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1

Young Eun Ha

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Jae-Hoon Song

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Won Ki Kang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Cheol-In Kang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Kyung Mok Shon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

8 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

Supportive Care in Cancer

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

1761-1767

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

15 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Bloodstream infections in cancer patients with febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Management of chemotherapy-associated febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Diagnosis and treatment of documented infections in neutropenic patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Updated review of blood culture contamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Bacteraemia in febrile neutropenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Science and pragmatism in the treatment and prevention of neutropenic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Risk of bacteraemia and mortality in patients with haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Bacterial infections in low-risk, febrile neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1017-4

Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group

21 January 2018

1 reference

12 December 2020

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

1 reference

12 December 2020

Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score

1 reference

12 December 2020

Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials

1 reference

12 December 2020

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

1 reference

12 December 2020

Improved prognosis for granulocytopenic patients with gram-negative bacteremia

1 reference

12 December 2020

10.1007/S00520-010-1017-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20931237%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

15 February 2020

1035052748

0 references

1 reference